136 related articles for article (PubMed ID: 37873100)
1. Mapping chromatin state and transcriptional response in CIC-DUX4 undifferentiated round cell sarcoma.
Thomas NJ; Luck C; Shlimon N; Ponce RK; Kosibaty Z; Okimoto RA
bioRxiv; 2023 Oct; ():. PubMed ID: 37873100
[TBL] [Abstract][Full Text] [Related]
2. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
[TBL] [Abstract][Full Text] [Related]
3. Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-DUX4 gene fusion.
Tsukamoto Y; Futani H; Yoshiya S; Watanabe T; Kihara T; Matsuo S; Hirota S
Pathol Res Pract; 2017 Oct; 213(10):1315-1321. PubMed ID: 28645808
[TBL] [Abstract][Full Text] [Related]
4. Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models.
Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Linardic CM; Kirsch DG
Res Sq; 2023 Oct; ():. PubMed ID: 37961185
[TBL] [Abstract][Full Text] [Related]
5. Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models.
Hendrickson PG; Oristian KM; Browne MR; Lou L; Ma Y; Cardona DM; Linardic CM; Kirsch DG
bioRxiv; 2023 Sep; ():. PubMed ID: 37808628
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the
Rekhi B; Kembhavi P; Mishra SN; Shetty O; Bajpai J; Puri A
Indian J Med Res; 2019 Dec; 150(6):557-574. PubMed ID: 32048619
[TBL] [Abstract][Full Text] [Related]
7. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
[TBL] [Abstract][Full Text] [Related]
8. CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas.
Bakaric A; Cironi L; Praz V; Sanalkumar R; Broye LC; Favre-Bulle K; Letovanec I; Digklia A; Renella R; Stamenkovic I; Ott CJ; Nakamura T; Antonescu CR; Rivera MN; Riggi N
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275898
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.
Bosnakovski D; Ener ET; Cooper MS; Gearhart MD; Knights KA; Xu NC; Palumbo CA; Toso EA; Marsh GP; Maple HJ; Kyba M
Oncogenesis; 2021 Oct; 10(10):68. PubMed ID: 34642317
[TBL] [Abstract][Full Text] [Related]
10. Distinct histologic and genetic characteristics of round cell sarcoma with CIC-DUX4 fusion and comparison with ewing sarcoma.
Song MJ; Cho KJ; Kim TI; Kim W; Song JS
Pathol Res Pract; 2022 Mar; 231():153779. PubMed ID: 35151033
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract][Full Text] [Related]
12. Ewing-like sarcoma with CIC-DUX4 gene fusion in a patient with neurofibromatosis type 1. A hitherto unreported association.
Tardío JC; Machado I; Navarro L; Idrovo F; Sanz-Ortega J; Pellín A; Llombart-Bosch A
Pathol Res Pract; 2015 Nov; 211(11):877-82. PubMed ID: 26386605
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice.
Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Nash JO; Ballester PL; Davidson S; Shlien A; Linardic CM; Kirsch DG
Oncogene; 2024 Apr; 43(16):1223-1230. PubMed ID: 38413794
[TBL] [Abstract][Full Text] [Related]
14. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma.
Ponce RKM; Thomas NJ; Bui NQ; Kondo T; Okimoto RA
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315355
[TBL] [Abstract][Full Text] [Related]
15. A t(4;19) pediatric undifferentiated sarcoma with a novel variant of the CIC-DUX4 fusion transcript.
Krskova L; Stejskalova E; Kabickova E; Mrhalova M; Kodet R
Pathol Res Pract; 2017 Mar; 213(3):281-285. PubMed ID: 28062084
[TBL] [Abstract][Full Text] [Related]
16. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas.
Graham C; Chilton-MacNeill S; Zielenska M; Somers GR
Hum Pathol; 2012 Feb; 43(2):180-9. PubMed ID: 21813156
[TBL] [Abstract][Full Text] [Related]
17. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
18. High-grade undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: emerging entities of soft tissue tumors with unique histopathologic features--a case report and literature review.
Haidar A; Arekapudi S; DeMattia F; Abu-Isa E; Kraut M
Am J Case Rep; 2015 Feb; 16():87-94. PubMed ID: 25683183
[TBL] [Abstract][Full Text] [Related]
19. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology.
Choi EY; Thomas DG; McHugh JB; Patel RM; Roulston D; Schuetze SM; Chugh R; Biermann JS; Lucas DR
Am J Surg Pathol; 2013 Sep; 37(9):1379-86. PubMed ID: 23887164
[TBL] [Abstract][Full Text] [Related]
20. A Rare Case of Round Cell Sarcoma with CIC-DUX4 Mutation Mimicking a Phlegmon: Review of Literature.
Donthi D; Malik P; Prenshaw KL; Hong H
Am J Case Rep; 2020 Sep; 21():e925683. PubMed ID: 32873768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
